BioWorld MedTech

Nov. 1, 2010

Meeting to focus on need and opportunity of obesity, diabetes

As the 8th annual Cleveland Clinic Medical Innovation Summit kicks off today, speakers from top companies in the industry will take aim at the war on obesity. (Medical Device Daily) Read More

Aethlon sets up shop in India for study of its Hemopurifier

Report from Europe: J&J facing slew of lawsuits in UK over faulty ASR hip implants

Washington roundup: GAO takes FDA to task over inspections of OUS facilities

Deals roundup: Coloplast buys Mpathy for up to $35 million

Financings roundup: Cappella secures €10.5M series D investment funding

Medical Device Daily Fun Facts

Agreements/contracts: PerkinElmer, KinaTech make cancer imaging technologies

People in the News

Product Briefs

Med-Tech Notes

MDD's Neurology Extra

Today's news in brief

BioWorld

BioWorld briefs for May 22, 2026.

Sangamo presents primate data for prion suppressor ST-506

BioWorld Science

Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...

TREM2 agonists detailed in Pfizer patent

BioWorld Science

Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.

Unmasking the X: EPAC2 shifts the fragile X landscape

BioWorld

Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...

Recludix presents STAT1/3 inhibitors for dermatological diseases

BioWorld Science

Recludix Pharma Inc. recently presented data on their new STAT1/3 inhibitors REX-6553 and REX-6547 for treating dermatological inflammatory skin diseases.